Identify Heart Attack and Stroke Risks

Diabetic Cardiomyopathy is a disorder of the heart muscle in people with diabetes. It can lead to the inability of the heart to circulate blood through the body effectively, a state known as heart failure, with an accumulation of fluid in the lungs (pulmonary edema) or legs (peripheral edema). Patients with diabetes Type 2 have up to a 74% increased risk of developing Heart Failure, and diabetic patients with HF are four times more likely to die than those without Heart Failure. Importantly, unrecognized Heart Failure is highly prevalent in Type 2 diabetics, with over one quarter (27.7%) of those over 60's having previously undiagnosed Heart Failure in one report. Therefore it is one, if not the, most important assessment to be measured for all Type 2 diabetic patients.

The ANS/HRV test is non-invasive and uses a photoelectric clip on the fingertip. By measuring the blood at the fingertip, the ANS/HRV can graph the heartbeat as it moves through systolic and diastolic. When a person’s arteries are flexible, the pressure at the fingertip has specific deviations as the arteries flex. The graph becomes very tight and regular if a person's arteries are stiff. The device performs an analysis of the arterial pulse wave by using a proprietary algorithm to track variations in the graph that are not visible to the naked eye and then interprets those results against a large body of research. The result is an assessment of arterial hardening that is very accurate.

Arterial Health Score: The 1-7 scoring system gives a very accurate assessment of arterial hardening.  The final report can also indicate instances where the patient has early congestive heart failure or heart weakening. This test allows you can detect arterial hardening or heart weakening long before the patient becomes symptomatic. This is crucial in diabetic patients and for patients with high blood pressure or elevated lipids.

Autonomic Balance Test: The machine also does a very accurate heart rate variability test and prints an autonomic nervous system analysis, showing if the person is overstressed and the sympathetic nervous system is dominant, or in some cases showing that the person is fatigued or the sympathetic is suppressed, and the parasympathetic system is dominant. It also shows how well the patient is dealing with their stress levels and assigns a stress score.

Long-Term Treatment: For long-term, longer-lasting treatments, you can see changes within 4-6 weeks of starting treatment.
Short-Term Treatments: Some fast-acting treatments (such as some fast absorption nitrous oxide products) can show changes within 10 or 20 minutes.

Features of the tests:

• 3-minute non-invasive assessment

• Measures the overall cardiovascular health

• Measures the left ventricle ejection and contraction power

• Measures mental stress, physical stress, and resistance to stress